Challenges for red blood cell biomarker discovery through proteomics

Area of Science:

• Biochemistry
• Hematology
• Proteomics

Background:

• Mature red blood cells (RBCs) lack organelles, limiting protein repair and making them susceptible to dysfunction.
• Aberrant RBCs are removed from circulation; rapid depletion causes hemolytic anemia (HA).
• Understanding RBCs under disease stress requires advanced proteomic analysis.

Purpose of the Study:

• To review challenges and strategies for in-depth red blood cell proteome analysis.
• To highlight the importance of discovering disease-specific biomarkers for various hemolytic anemias.
• To discuss the utility of proteomic insights for clinical applications, including transfusion medicine.

Main Methods:

• Proteome analysis of red blood cells.
• Identification and quantification of proteins.
• Biomarker discovery and validation.

Main Results:

• Proteome analysis provides a direct method to understand RBCs under disease stress.
• Challenges include obtaining pure RBCs, managing wide protein dynamic ranges, and determining protein activity.
• Identifying unique biomarkers for RBC aging, thalassemias, sickle cell disease, and rare RBC disorders remains a key objective.

Conclusions:

• Proteomics is essential for deciphering RBC biology and identifying biomarkers for hemolytic anemias.
• Overcoming technical challenges in RBC proteome analysis is critical for clinical advancements.
• Validated biomarkers will improve diagnosis, treatment, and understanding of RBC disorders.